UBS AM’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.81M | Buy |
320,804
+32,670
| +11% | +$592K | ﹤0.01% | 1641 |
|
|
2025
Q1 | $5.9M | Buy |
288,134
+34,563
| +14% | +$708K | ﹤0.01% | 1488 |
|
|
2024
Q4 | $6.52M | Buy |
253,571
+14,288
| +6% | +$367K | ﹤0.01% | 1468 |
|
|
2024
Q3 | $3.97M | Buy |
239,283
+221,305
| +1,231% | +$3.67M | ﹤0.01% | 1694 |
|
|
2024
Q2 | $345K | Buy |
+17,978
| New | +$345K | ﹤0.01% | 2701 |
|